Metraipolis › archive › dc_e3ecb3159288

A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal… — Europe PMC PMID:41900775

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41900775
DOI
10.3390/pharmaceutics18030287
License (as archived)
solo-consultazione
Archived
2026-10-18T11:05:18.230Z
SHA-256 of the archived text
4f7ca93343fa1732ab6cbf76645568d1218012367124425de36bf43b82a43ae2
Stable URL of this page
https://metraipolis.com/documento/dc_e3ecb3159288

How to cite

A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal… — Europe PMC PMID:41900775 — Europe PMC (en), https://europepmc.org/article/MED/41900775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e3ecb3159288 (Metraipolis archive dc_e3ecb3159288, sha256 4f7ca93343fa1732ab6cbf76645568d1218012367124425de36bf43b82a43ae2)
BibTeX
@misc{dce3ecb3159288,
  title = {A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal… — Europe PMC PMID:41900775},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41900775},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e3ecb3159288; sha256 4f7ca93343fa1732ab6cbf76645568d1218012367124425de36bf43b82a43ae2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41900775. Agents can read the archived copy with the MCP tool read_document.